GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
P

Pila Pharma PILA.ST · SEK

Health Care · Nasdaq Stockholm · 🇸🇪 Sweden

Compare

1.62

+1.89%

Close of 9 Nov 2026, in SEK

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in SEK, from our data supplier.

FY2025

Revenue

SEK 1.1m

FY2016FY2025

Net income

−SEK 16.9m

FY2016FY2025

Free cash flow

−SEK 9.2m

FY2016FY2025

Shareholders' equity

SEK 14.8m

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
RevenueSEK 1.1mSEK 775,000SEK 1.5mSEK 1.9mSEK 719,230—SEK 346,436———
Gross profit−SEK 5.7m−SEK 8.1mSEK 1.5mSEK 1.9mSEK 680,939−SEK 492,392−SEK 2.1m−SEK 2.9m−SEK 7,533−SEK 379,884
Operating income−SEK 7.9m−SEK 8.1m−SEK 6.4m−SEK 8.9m−SEK 9.3m−SEK 3.4m−SEK 8.7m−SEK 5.0m−SEK 4.8m−SEK 1.5m
Net income−SEK 16.9m−SEK 11.2m−SEK 9.9m−SEK 26.8m−SEK 17.2m−SEK 10.6m−SEK 8.7m−SEK 5.6m−SEK 4.8m−SEK 1.5m
Diluted earnings per share-0.40-0.41-0.47-1.55-1.04-0.67-0.24-0.15-0.13-0.04

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assetsSEK 16.2mSEK 6.2mSEK 8.5mSEK 10.9mSEK 31.8mSEK 5.4mSEK 7.9mSEK 7.3mSEK 7.5mSEK 1.3m
Cash and short-term investmentsSEK 15.9mSEK 4.9mSEK 6.0mSEK 7.2mSEK 28.2mSEK 1.9mSEK 4.1mSEK 3.4mSEK 6.8mSEK 1.1m
Total liabilitiesSEK 1.4mSEK 963,000SEK 1.8mSEK 1.4mSEK 1.5mSEK 1.9mSEK 484,678SEK 821,979SEK 561,366SEK 644,761
Debt——SEK 773,080——SEK 500,000——SEK 80,000SEK 440,000
Shareholders' equitySEK 14.8mSEK 5.3mSEK 6.7mSEK 9.5mSEK 30.3mSEK 3.4mSEK 7.5mSEK 6.5mSEK 7.0mSEK 645,508
Shares outstanding42m27m21m17m16m16m36m36m36m36m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations−SEK 9.2m−SEK 7.8m−SEK 4.9m−SEK 9.1m−SEK 9.4m−SEK 2.0m−SEK 5.0m−SEK 4.6m——
Capital spending—−SEK 4————−SEK 15,072−SEK 3.2m——
Free cash flow−SEK 9.2m−SEK 7.8m−SEK 4.9m−SEK 9.1m−SEK 9.4m−SEK 2.0m−SEK 5.0m−SEK 7.7m——

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
Revenue——SEK 137,870SEK 137,870SEK 425,500SEK 425,500SEK 53,445SEK 53,445
Gross profit−SEK 1.8m−SEK 1.8m−SEK 1.2m−SEK 1.2m−SEK 1.8m−SEK 1.8mSEK 1.9mSEK 1.9m
Operating income−SEK 1.9m−SEK 1.9m−SEK 2.0m−SEK 2.0m−SEK 2.0m−SEK 2.0m−SEK 2.0m−SEK 2.0m
Net income−SEK 1.9m−SEK 1.9m−SEK 6.5m−SEK 6.5m−SEK 2.1m−SEK 2.1m−SEK 3.6m−SEK 3.6m
Diluted earnings per share-0.05-0.05-0.15-0.15-0.05-0.05-0.13-0.13
Cash from operations−SEK 8.0m−SEK 8.0m−SEK 1.0m−SEK 1.0m−SEK 1.0m−SEK 1.0m−SEK 2.0m−SEK 2.0m
Total assetsSEK 16.9mSEK 16.9mSEK 16.2mSEK 16.2mSEK 3.5mSEK 3.5mSEK 6.2mSEK 6.2m
Cash and short-term investmentsSEK 3.3mSEK 3.3mSEK 15.9mSEK 15.9mSEK 1.1mSEK 1.1mSEK 4.9mSEK 4.9m
Shareholders' equitySEK 16.1mSEK 16.1mSEK 14.8mSEK 14.6mSEK 1.2mSEK 1.2mSEK 5.3mSEK 5.3m

Growth per year

Compound annual rate

3 years5 years10 years
Revenue-15.7%——
Operating income-3.9%18.5%24.3%
Net income-14.3%9.8%34.0%

Average margins

Over each period

1 year3 years5 years10 years
Gross margin-728.9%-200.6%——
Operating margin-841.4%-596.4%——
Net margin-1477.6%-1235.5%——

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021
Price to earnings-3.3-5.8-2.2-1.3-4.1
Price to sales49.183.714.718.197.1

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.